[ABCL] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 0.00%
YoY-
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 7,323 10,056 45,917 27,643 11,228 2,479 24.15%
PBT -48,187 -38,004 -6,886 -2,073 6,703 -303 175.30%
Tax -11,257 -7,476 -101 250 0 0 -
NP -36,930 -30,528 -6,785 -2,323 6,703 -303 161.05%
Tax Rate - - - - 0.00% - -
Total Cost 44,253 40,584 52,702 29,966 4,525 2,782 73.80%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin -504.30 -303.58 -14.78 -8.40 59.70 -12.22 110.26%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -0.13 -0.11 -0.02 -0.01 0.03 -0.00 -
EPS Diluted -0.13 -0.11 -0.02 -0.01 0.03 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.